Abeona Therapeutics Inc. (ABEO) Social Stream
ABEONA THERAPEUTICS INC (ABEO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ABEO.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 2 | $5 | $5 | $5 | $5.63 | -11.19% |
| 2021-11-18 | 3 | $5 | $5 | $5 | $5.63 | -11.19% |
| 2021-11-29 | 3 | $5 | $4 | $4.666 | $5.63 | -17.12% |
| 2021-11-30 | 3 | $5 | $1 | $3.333 | $5.63 | -40.8% |
| 2022-03-31 | 3 | $4 | $1 | $3 | $5.63 | -46.71% |
| 2022-04-01 | 3 | $4 | $1 | $2.666 | $5.63 | -52.65% |
| 2022-05-13 | 2 | $3 | $1 | $2 | $5.63 | -64.48% |
| 2022-05-18 | 2 | $2 | $1 | $1.5 | $5.63 | -73.36% |
| 2022-07-18 | 2 | $15 | $1 | $8 | $5.63 | 42.1% |
| 2022-11-03 | 2 | $22 | $5 | $13.5 | $5.63 | 139.79% |
| 2022-11-08 | 2 | $40 | $5 | $22.5 | $5.63 | 299.64% |
| 2022-11-15 | 2 | $38 | $6 | $22 | $5.63 | 290.76% |
| 2023-03-30 | 1 | $38 | $38 | $38 | $5.63 | 574.96% |
| 2023-05-12 | 1 | $38 | $10 | $24 | $5.63 | 326.29% |
| 2023-05-30 | 1 | $38 | $10 | $22.666 | $5.63 | 302.59% |
| 2023-08-09 | 2 | $38 | $10 | $21.5 | $5.63 | 281.88% |
| 2023-08-11 | 2 | $38 | $8 | $21 | $5.63 | 273% |
| 2023-08-30 | 2 | $38 | $8 | $20.5 | $5.63 | 264.12% |
| 2023-11-29 | 2 | $38 | $11 | $21.25 | $5.63 | 277.44% |
The Trend in the Analyst Price Target
Over the past 43 months, ABEO's average price target has gone up $11.82.
Over the past 35 weeks, ABEO's average upside potential has been 579.9%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-30 | 1 | 38 | 38 | 38.00 | 2.83 | 1242.76% |
| 2023-07-13 | 2 | 38 | 10 | 21.50 | 3.99 | 438.85% |
| 2023-08-09 | 2 | 38 | 10 | 21.50 | 3.00 | 616.67% |
| 2023-11-15 | 2 | 38 | 11 | 21.25 | 4.15 | 412.05% |
| 2023-11-29 | 2 | 38 | 11 | 21.25 | 4.90 | 333.67% |
ABEO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 18 months, ABEO's average broker recommendation rating improved by 1.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABEO as an investment opportunity.
- ABEO has a higher number of analysts covering the stock than 70.86% of all US stocks.
- ABEONA THERAPEUTICS INC's variance in analysts' estimates is lower than -1393.74% of all US stocks.
- In the context of all US stocks, ABEONA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1101.5% of them.
- In the context of Healthcare stocks, ABEONA THERAPEUTICS INC's average analyst price target is higher than 460.56% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ABEONA THERAPEUTICS INC are SYRS, CLSD, and MRKR.
View All Top Stocks by Price Target
Is ABEO a Buy, Hold or Sell? See the POWR Ratings now!